Table 4.
Univariate and multivariate logistic regression analyses for predictors of TO.
| Variables | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | p | OR (95% CI) | P | |
| Diabetes (yes vs. no) | 1.03 (0.44–2.42) | 0.942 | ||
| Hypertension (yes vs. no) | 1.20 (0.61–2.36) | 0.596 | ||
| CHD (yes vs. no) | 1.38 (0.30–6.29) | 0.675 | ||
| HBV (yes vs. no) | 1.16 (0.48–2.79) | 0.738 | ||
| Liver cirrhosis (yes vs. no) | 0.27 (0.08–0.92) | 0.037 | 0.38 (0.11~ 1.37) | 0.139 |
| ASA (III/IV vs. I/II) | 0.88 (0.55–1.40) | 0.58 | ||
| Preoperative comorbidities (yes vs. no) | 0.94 (0.56–1.55) | 0.795 | ||
| Age (≥60 vs. <60) | 1.06 (0.67–1.67) | 0.817 | ||
| Albumin (≥35 vs. <35) | 0.99 (0.58–1.69) | 0.965 | ||
| ALT (≥42 vs. <42) | 0.84 (0.45–1.57) | 0.589 | ||
| Total bilirubin (≥42 vs. <42) | 0.51 (0.28–0.94) | 0.029 | 0.62 (0.32–1.19) | 0.151 |
| Large-scale liver resection (yes vs. no) | 0.59 (0.35–0.99) | 0.049 | 0.70 (0.40–1.23) | 0.216 |
| PVR (yes vs. no) | 0.41 (0.21–0.80) | 0.008 | 0.48 (0.24–0.99) | 0.046 |
| HAR (yes vs. no) | 0.57 (0.24–1.39) | 0.218 | ||
| PVR and HAR (yes vs. no) | 0.71 (0.22–2.32) | 0.573 | ||
| Poor differentiation (yes vs. no) | 0.89 (0.49–1.62) | 0.705 | ||
| Lymph node metastasis (yes vs. no) | 0.66 (0.41–1.07) | 0.091 | ||
| PTBD (yes vs. no) | 0.74 (0.46–1.20) | 0.228 | ||
| Bismuth (III/IV vs. I/II) | 0.84 (0.51–1.40) | 0.506 | ||
TO, textbook outcome; CHD, coronary heart disease; ALT, alanine aminotransferase; PVR, portal vein reconstruction; PTBD, percutaneous transhepatic biliary drainage; ASA, American Society of Anesthesiologists Physical Status Classification System; HAR, Hepatic artery reconstruction.